37 Results for "

Citrate lyase

" in MedChemExpress (MCE) Product Catalog:
Products (37)

37 Results for "Citrate lyase" in MCE Product Catalog:

Cat. No.: HY-P2843
CAS No.: 9012-83-3
Research Areas:  

Infection

Citrate lyase is a magnesium-dependent citrate lyase. Citrate lyase is composed of α, β, and γ subunits, of which γ is an acyl carrier protein. Citrate lyase catalyzes the cleavage of Citrate into Acetate and Oxaloacetate. Citrate lyase can be used in research on Klebsiella pneumoniae and Escherichia coli infections .
loading...
    loading...
28
28 Publications Verification
Cat. No.: HY-16450
CAS No.: 154566-12-8
Target:  

ATP Citrate Lyase

Research Areas:  

Metabolic Disease

SB 204990 is a potent and specific inhibitor of ATP citrate lyase (ACLY) enzyme.
loading...
    loading...
26
26 Cited Publications
Cat. No.: HY-16107
CAS No.: 943962-47-8
Target:  

ATP Citrate Lyase

Research Areas:  

Metabolic Disease

BMS-303141 is a potent, cell-permeable ATP-citrate lyase (ACL) inhibitor with an IC50 of 0.13 μM.
loading...
    loading...
25
25 Cited Publications
Cat. No.: HY-12357
CAS No.: 738606-46-7
Purity:  99.97%
Synonyms: ETC-1002; ESP-55016
Target:  

ATP Citrate Lyase AMPK

Research Areas:  

Metabolic Disease

Bempedoic acid (ETC-1002) is an ATP-citrate lyase (ACL) inhibitor . Bempedoic acid (ETC-1002) activates AMPK .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-127111
CAS No.: 2375840-87-0
Purity:  99.54%
Target:  

ATP Citrate Lyase

Research Areas:  

Cancer

NDI-091143 is a potent and high-affinity human ATP-citrate lyase (ACLY) inhibitor with an IC50 of 2.1 nM (ADP-Glo assay), a Ki of 7.0 nM and a Kd of 2.2 nM. NDI-091143 inhibits ACLY catalysis allosterically, by stabilizing large conformational changes in the citrate domain that indirectly block the binding and recognition of citrate .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P72070
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: ACLY; ATP-Citrate (Pro-S-)-lyase; ATP Citrate lyase; Citrate Cleavage Enzyme; ACL; ATP-Citrate Synthase; ATPCL; ATP Citrate Synthase; CLATP
Species:  
Human
Source:  
E. coli
loading...
    loading...
Cat. No.: HY-175606
CAS No.: 2588489-03-4
Target:  

ATP Citrate Lyase

Research Areas:  

Cancer

EVT0185 is an orally active ATP citrate lyase (ACLY) inhibitor. EVT0185 is converted to a CoA thioester in the liver by SLC27A2 and interacts with the CoA-binding site of ACLY. EVT0185-CoA inhibits ACLY activity with an IC50 of 2.5 μM. EVT0185 can phenocopy the immune and antitumour effects of genetic ACLY deletion. EVT0185 can increase tumour-infiltrating B cells and chemokine CXCL13 levels. EVT0185 can be used for the research of cancer, such as hepatocellular carcinoma (HCC) .
loading...
    loading...
Cat. No.: HY-P1123
CAS No.: 87272-20-6
MEDICA16 is an orally active acetyl-CoA carboxylase and ATP-citrate lyase inhibitor. MEDICA16 limits the acetyl-CoA supply for acetyl-CoA carboxylase, inhibits acetyl-CoA carboxylase activity, exerts citrate-competitive inhibitory effects on ATP-citrate lyase, and reduces hepatic AMPK activity. MEDICA16 can be used in research related to insulin resistance, hyperlipidemia, and obesity .
loading...
    loading...
Cat. No.: HY-N7347
CAS No.: 27750-13-6
Synonyms: Garcinia lactone
(-)-Hydroxycitric acid lactone (Garcinia lactone) is an anti-obesity agent and a popular weight loss food supplement. (-)-Hydroxycitric acid lactone is a potent inhibitor of ATP-citrate lyase. (-)-Hydroxycitric acid lactone catalyzes the extramitochondrial cleavage of citrate to oxaloacetate and acetyl-CoA, limits the availability of acetyl-CoA units required for fatty acid synthesis .
loading...
    loading...
Cat. No.: HY-17640
CAS No.: 1269181-69-2
Research Areas:  

Metabolic Disease

Nicodicosapent is a fatty acid niacin conjugate that is also an inhibitor of the sterol regulatory element binding protein (SREBP), a key regulator of cholesterol metabolism proteins such as PCSK9, HMG-CoA reductase, ATP citrate lyase, and NPC1L1.
loading...
    loading...
Cat. No.: HY-136584
CAS No.: 413624-71-2
Purity:  ≥98.0%
ESP15228 is a metabolite of Bempedoic acid (HY-12357). ESP15228 undergoes glucuronidation to form ESP15228-glucuronide. ESP15228 can form excretory ESP15228-taurine conjugate in feces. ESP15228-CoA is a selective hepatic ATP citrate lyase inhibitor. ESP15228 can be used in the research of hypercholesterolemia .
loading...
    loading...
Cat. No.: HY-12357S2
CAS No.: 2408131-70-2
Purity:  ≥98.0%
Synonyms: ETC-1002-d4; ESP-55016-d4
Bempedoic acid-d4 is the deuterium labeled Bempedoic acid. Bempedoic acid (ETC-1002) is an ATP-citrate lyase (ACL) inhibitor. Bempedoic acid (ETC-1002) activates AMPK .
loading...
    loading...
Cat. No.: HY-177136
CAS No.: 3009136-86-8
ACLY-IN-2 (Compound 7) has inhibitory effect against human ATP citrate lyase (hACLY), with an IC50 of less than 1 nM. ACLY-IN-2 can be studied in research on liver-related diseases, type-2 diabetes, autoimmunity, and cancer .
loading...
    loading...
Cat. No.: HY-12357S
CAS No.: 2408131-71-3
Synonyms: ETC-1002-d5; ESP-55016-d5
Bempedoic acid-d5 is the deuterium labeled Bempedoic acid . Bempedoic acid (ETC-1002) is an ATP-citrate lyase (ACL) inhibitor . Bempedoic acid (ETC-1002) activates AMPK .
loading...
    loading...
Cat. No.: HY-12357R
CAS No.: 738606-46-7
Synonyms: ETC-1002 (Standard); ESP-55016 (Standard)
Bempedoic acid (Standard) is the analytical standard of Bempedoic acid. This product is intended for research and analytical applications. Bempedoic acid (ETC-1002) is an ATP-citrate lyase (ACL) inhibitor . Bempedoic acid (ETC-1002) activates AMPK .
loading...
    loading...
Cat. No.: HY-P2843A
Research Areas:  

Metabolic Disease

Citrate Lyase, Klebsiella pneumoniae (EC 4.1.3.6) catalyzes the first step of Citrate degradation, forming acetate and oxaloacetate. Citrate Lyase, Klebsiella pneumoniae (EC 4.1.3.6) contains 3 polypeptide subunits, α-subunit (a transferase), β-subunit (acyl lyase) and γ-subunit (acyl-carrier protein).
loading...
    loading...
Cat. No.: HY-P1123R
CAS No.: 87272-20-6
MEDICA16 (Standard) is the analytical standard of MEDICA16 (HY-P1123). This product is intended for research and analytical applications. MEDICA16 is an orally active acetyl-CoA carboxylase and ATP-citrate lyase inhibitor. MEDICA16 limits the acetyl-CoA supply for acetyl-CoA carboxylase, inhibits acetyl-CoA carboxylase activity, exerts citrate-competitive inhibitory effects on ATP-citrate lyase, and reduces hepatic AMPK activity. MEDICA16 can be used in research related to insulin resistance, hyperlipidemia, and obesity .
loading...
    loading...
Cat. No.: HY-N12336
CAS No.: 308105-06-8
Gnetuhainin I (Compound 5) is a lignin derived from Pouzolzia zeylanica. Gnetuhainin I shows good inhibitory effect on ATP citrate lyase (ACLY) (IC50=2.63 μM) .
loading...
    loading...
Cat. No.: HY-N7347R
CAS No.: 27750-13-6
Synonyms: Garcinia lactone (Standard)
(-)-Hydroxycitric acid lactone (Standard) is the analytical standard of (-)-Hydroxycitric acid lactone. This product is intended for research and analytical applications. (-)-Hydroxycitric acid lactone (Garcinia lactone) is an anti-obesity agent and a popular weight loss food supplement. (-)-Hydroxycitric acid lactone is a potent inhibitor of ATP-citrate lyase. (-)-Hydroxycitric acid lactone catalyzes the extramitochondrial cleavage of citrate to oxaloacetate and acetyl-CoA, limits the availability of acetyl-CoA units required for fatty acid synthesis .
loading...
    loading...
Cat. No.: HY-P80380
Synonyms: ATP-Citrate synthase, ATP-Citrate (pro-S-)-lyase, Citrate cleavage enzyme, ACL, ACLY

Host:  

Rabbit

Application:  

WB, ICC/IF, IHC-P, IP, FC

Reactivity:  

Human, Mouse

loading...
    loading...